Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study

A. Rambaldi, A. Iurlo, A.M. Vannucchi, R. Noble, N. von Bubnoff, A. Guarini, B. Martino, A. Pezzutto, G. Carli, M. De Muro, S. Luciani, M.F. McMullin, N. Cambier, J.-P. Marolleau, R.A. Mesa, R. Tibes, A. Pancrazzi, F. Gesullo, P. Bettica, S. ManzoniS. Di Tollo

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2234-2237
Number of pages4
JournalLeukemia
Volume34
Issue number8
DOIs
Publication statusPublished - 2020

Cite this

Rambaldi, A., Iurlo, A., Vannucchi, A. M., Noble, R., von Bubnoff, N., Guarini, A., Martino, B., Pezzutto, A., Carli, G., De Muro, M., Luciani, S., McMullin, M. F., Cambier, N., Marolleau, J-P., Mesa, R. A., Tibes, R., Pancrazzi, A., Gesullo, F., Bettica, P., ... Di Tollo, S. (2020). Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study. Leukemia, 34(8), 2234-2237. https://doi.org/10.1038/s41375-020-0735-y